CIK 0000875045 · Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330112644
- Phone
- 6176792000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- DEFC14A Other DEFC14A
- DEFA14A Proxy Proxy Materials
- DFAN14A Other Proxy Soliciting Materials
- DFAN14A Other Proxy Soliciting Materials
- DEFA14A Proxy Proxy Materials
- 8-K Event Executive or director change
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- DEFC14A Other DEFC14A
- PRRN14A Other PRRN14A
- PRER14A Other PRER14A
- UPLOAD Other SEC-generated Letter
- 3 Insider Initial Statement of Ownership
- UPLOAD Other SEC-generated Letter
- 10-Q Report Quarterly Report
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- 8-K Event Results of operations
Page 82 of 137 · 2,721 filings